Rosetta Genomics and the Medical Dilemma of CUP
February 4, 2013
It’s a disease medical science has been battling for years. Cancer continues to claims millions of lives in the United States. But a cutting-edge technology, called MicroRNA Testing, hold promise in our collective effort to identify tumor origins. Tune-in to The Balancing Act as they discuss where this technology is…where it may be going…and how it’s helping patients and doctors defeat this dreaded disease.
Don’t move! The Balancing Act is back with a new Behind the Mystery segment and an inside look at a Broadway sensation.
We're discussing Alport syndrome, a rare, genetic, and chronic kidney condition characterized by declining kidney function which can lead to end-stage kidney disease.
When it comes to facial and body rejuvenation, discover a patient-first, non-surgical approach at Jupiter Plastic Surgery Center.